Marsh & McLennan Companies, Inc. (NYSE:MMC) stands out in the insurance brokerage sector for its global presence and esteemed reputation. The company is distinguished by its ability to deliver industry-leading returns on capital, setting it apart from its competitors. MMC's financial health is robust, demonstrated by its strong earnings and successful integration of acquisitions like McGriff, even amidst challenges such as softening insurance rates.
On July 21, 2025, Brian Meredith from UBS set a price target of $258 for MMC, suggesting a potential upside of approximately 21.21% from its current trading price of $212.86. This adjustment from a previous target of $261 reflects confidence in MMC's ability to navigate industry challenges and leverage its competitive advantages. The stock's current price of $212.55, with a slight increase of 0.13% or $0.27, signals market stability and investor interest.
MMC's valuation is compelling, with a lower price-to-earnings (P/E) ratio, making it an attractive option for investors. The company's strong cash flow and profit margins support manageable debt levels, ensuring continued resilience. Despite increased debt from the McGriff acquisition, MMC's financial metrics remain robust, highlighting its ability to sustain growth and profitability.
The stock has exhibited some volatility, with today's price fluctuating between a low of $211.28 and a high of $213.75. Over the past year, MMC has reached a high of $248 and a low of $207.21, reflecting its market dynamics. With a substantial market capitalization of approximately $104.57 billion and a trading volume of 727,749 shares, MMC remains a significant player in the insurance brokerage industry.
